First National Trust CO Eli Lilly & CO Transaction History

First National Trust CO

$2.56 Billion
Q3 2024

A detailed history of First National Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, First National Trust CO holds 30,939 shares of LLY stock, worth $23.7 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares

30,939

Previous 31,144 0.66%

Holding current value

$23.7 Million

Previous $28.2 Million 2.79%

% of portfolio

1.07%

Previous 1.17%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$772.14 - $960.02 $158,288 - $196,804	-205 Reduced 0.66%	30,939 $27.4 Million
Q2 2024 Aug 02, 2024	BUY	$724.87 - $909.04 $1.11 Million - $1.4 Million	1,536 Added 5.19%	31,144 $28.2 Million
Q1 2024 Apr 26, 2024	BUY	$592.2 - $792.28 $2.68 Million - $3.59 Million	4,527 Added 18.05%	29,608 $23 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $173,312 - $204,312	-330 Reduced 1.3%	25,081 $14.6 Million
Q3 2023 Nov 06, 2023	SELL	$434.7 - $599.3 $97,372 - $134,243	-224 Reduced 0.87%	25,411 $13.6 Million
Q2 2023 Aug 01, 2023	SELL	$350.74 - $468.98 $158,534 - $211,978	-452 Reduced 1.73%	25,635 $12 Million
Q1 2023 Apr 26, 2023	SELL	$310.63 - $364.82 $115,243 - $135,348	-371 Reduced 1.4%	26,087 $8.96 Million
Q4 2022 Feb 02, 2023	SELL	$321.55 - $374.67 $165,598 - $192,955	-515 Reduced 1.91%	26,458 $9.68 Million
Q3 2022 Nov 02, 2022	SELL	$296.48 - $337.87 $113,551 - $129,404	-383 Reduced 1.4%	26,973 $8.72 Million
Q2 2022 Aug 03, 2022	SELL	$278.73 - $327.27 $402,207 - $472,250	-1,443 Reduced 5.01%	27,356 $8.87 Million
Q1 2022 May 03, 2022	SELL	$234.69 - $291.66 $166,395 - $206,786	-709 Reduced 2.4%	28,799 $8.25 Million
Q4 2021 Feb 03, 2022	SELL	$224.85 - $279.04 $258,127 - $320,337	-1,148 Reduced 3.74%	29,508 $8.15 Million
Q3 2021 Nov 05, 2021	SELL	$221.6 - $272.71 $68,917 - $84,812	-311 Reduced 1.0%	30,656 $7.08 Million
Q2 2021 Aug 06, 2021	SELL	$180.55 - $233.54 $218,646 - $282,816	-1,211 Reduced 3.76%	30,967 $7.11 Million
Q1 2021 May 06, 2021	SELL	$164.32 - $212.72 $210,493 - $272,494	-1,281 Reduced 3.83%	32,178 $6.01 Million
Q4 2020 Feb 10, 2021	SELL	$130.46 - $172.63 $228,826 - $302,793	-1,754 Reduced 4.98%	33,459 $5.65 Million
Q3 2020 Nov 04, 2020	SELL	$146.22 - $169.13 $99,868 - $115,515	-683 Reduced 1.9%	35,213 $5.21 Million
Q2 2020 Aug 06, 2020	SELL	$136.42 - $164.18 $94,948 - $114,269	-696 Reduced 1.9%	35,896 $5.89 Million
Q1 2020 Apr 29, 2020	SELL	$119.05 - $147.35 $210,004 - $259,925	-1,764 Reduced 4.6%	36,592 $5.08 Million
Q4 2019 Feb 04, 2020	SELL	$106.92 - $132.43 $137,819 - $170,702	-1,289 Reduced 3.25%	38,356 $5.04 Million
Q3 2019 Nov 01, 2019	SELL	$106.79 - $116.16 $317,913 - $345,808	-2,977 Reduced 6.98%	39,645 $4.43 Million
Q2 2019 Jul 22, 2019	SELL	$110.79 - $129.32 $229,335 - $267,692	-2,070 Reduced 4.63%	42,622 $4.72 Million
Q1 2019 Apr 25, 2019	SELL	$111.31 - $131.02 $354,856 - $417,691	-3,188 Reduced 6.66%	44,692 $5.8 Million
Q4 2018 Jan 28, 2019	SELL	$105.9 - $118.64 $278,411 - $311,904	-2,629 Reduced 5.21%	47,880 $5.54 Million
Q3 2018 Oct 31, 2018	SELL	$85.86 - $107.31 $138,749 - $173,412	-1,616 Reduced 3.1%	50,509 $0
Q2 2018 Jul 30, 2018	SELL	$75.7 - $86.88 $107,418 - $123,282	-1,419 Reduced 2.65%	52,125 $4.45 Million
Q1 2018 Apr 30, 2018	SELL	$74.21 - $87.6 $565,702 - $667,774	-7,623 Reduced 12.46%	53,544 $4.14 Million
Q4 2017 Jan 17, 2018	SELL	$81.94 - $87.89 $352,260 - $377,839	-4,299 Reduced 6.57%	61,167 $5.17 Million
Q3 2017 Nov 06, 2017	SELL	$77.07 - $85.54 $490,858 - $544,804	-6,369 Reduced 8.87%	65,466 $5.6 Million
Q2 2017 Aug 07, 2017	BUY	N/A	71,835	71,835 $5.91 Million

Others Institutions Holding LLY

# of Institutions

4,031

Shares Held

739M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $728B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on First National Trust CO with notifications on news.

Account

First National Trust CO Eli Lilly & CO Transaction History